Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively

NCT01868243 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped because a significant decrease of viable candidates for the study.

Conditions

Primary Disease

Interventions

DRUG: Dabigatran
DRUG: Warfarin

Sponsor

Hospital Ana Nery